Open AccessManagement of Cough in Patients with Chronic Obstructive Pulmonary Disease: Results of the Multicenter Randomized Placebo-Controlled Clinical Trial
Author(s) -
S. N. Avdeev,
А. А. Визель,
Vladimir Abrosimov,
Andrey A Zaicev,
Г. Л. Игнатова,
Р. Ф. Хамитов,
M. P. Mikhaylusova,
Julia Shapovalova,
Elena Pavlysh,
Basil I Trofimov,
Alexander Emelyanov,
Tatiana Martynenko,
Vladimir A Martynenko,
N. E. Kostina,
Danila A Chizhov,
O. Yu. Chizhova,
Н. А. Кузубова,
Elena V Makova,
E. V. Makarova
Publication year - 2021
Publication title -
international journal of chronic obstructive pulmonary disease/international journal of copd
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.394
H-Index - 67
eISSN - 1178-2005
pISSN - 1176-9106
DOI - 10.2147/copd.s292109
Subject(s) - medicine , copd , placebo , spirometry , chronic cough , randomized controlled trial , asthma , quality of life (healthcare) , anesthesia , pathology , alternative medicine , nursing
Chronic cough declines quality of life and increases risk of complications in patients with chronic obstructive pulmonary disease (COPD). Reducing cough severity and associated negative effects is important therapeutic goal in COPD. Rengalin with anti- and protussive activity is based on technologically processed antibodies to bradykinin, histamine and morphine.